Anadolu Medical Center
| トルコ | オーストリア | スペイン | |
| 肺高血圧症幹細胞治療 | から $12,000 | から $55,000 | から $25,000 |
| LDLアフェレーシス | から $1,650 | - | - |
Dr. Ertugrul Okuyan is an interventional cardiologist at Medipol Acibadem District Hospital in Istanbul. He specializes in treating structural heart disease and complex valve disorders. Dr. Okuyan serves as the Vice President of the Turkish Society of Cardiology. He is also a member of the European Society of Cardiology.
Dr. Cemsit Karakurt is the Head of Child Health at İnönü University Faculty of Medicine. He resides on the board of the Turkish Society of Paediatric Cardiology. Dr. Karakurt treats children with complex heart conditions at Medical Park Antalya Hospital. He specializes in managing arrhythmia, coronary artery disease, and pulmonary hypertension.
イブラヒム・ハリル・タンボガ教授は、ヒサール・ホスピタル・インターコンチネンタルにて、高度な技術を用いて肺高血圧症の診断と治療を専門としています。
Dr. Remziye Dogan is a cardiologist at Hisar Hospital Intercontinental in Istanbul. She specializes in the diagnosis and treatment of coronary artery disease and heart failure. Dr. Dogan serves at a JCI-accredited facility that treats 500,000+ patients annually.
Turkey is a premier destination for pulmonary hypertension treatment. The country features Joint Commission International-accredited hospitals and cardiologists trained at global centers like the Royal Brompton Hospital. Dedicated clinics provide advanced diagnostics and specialized therapies including stem cell treatment and pulmonary endarterectomy.
Bookimed Expert Insight: While many seek Turkey for lower costs, our data shows a shift toward specialized stem cell protocols. These packages often reach $18,000. This higher price point reflects specialized cellular processing not found in standard cardiology clinics. This focus on regenerative options attracts patients who have exhausted traditional medications.
Patient Consensus: Patients note that medical credentials matter more than modern hospital decor for this complex disease. They emphasize checking if a center provides a clear long-term monitoring plan before booking.
Turkey offers advanced pulmonary hypertension treatments including targeted pharmacological therapies, surgical interventions like thromboendarterectomy, and minimally invasive balloon pulmonary angioplasty. Leading JCI-accredited centers in Istanbul provide multidisciplinary care following international ESC and ERS guidelines for pulmonary arterial hypertension and chronic thromboembolic conditions.
Bookimed Expert Insight: While pharmacological care is standardized, surgical expertise is concentrated in high-volume centers. For instance, Dr. Hasan Yucel at Medicana Sivas has performed over 10,000 valve-related procedures. This depth of surgical experience often leads to more predictable outcomes for complex cardiovascular interventions linked to hypertension.
Patient Consensus: Patients value the rapid access to advanced diagnostics and international medications. Many emphasize following the guidance of major university hospitals in Istanbul or Ankara to ensure strict adherence to global treatment protocols.
Turkish medical centers report a 70.6% 10-year survival rate for pulmonary endarterectomy patients. This is significantly higher than the 41.7% survival seen in non-operated cases. Key institutions like Medipol Mega University Hospital and Memorial Bahçelievler maintain high success metrics for complex cardiovascular procedures.
Bookimed Expert Insight: Success in CTEPH surgery is directly linked to clinic volume. Medipol Mega University Hospital serves over 1,200 patients daily. This high volume often correlates with better outcomes for rare, technically demanding procedures. Patients should prioritize clinics with multidisciplinary departments to ensure safe perioperative care.
Patient Consensus: Patients note that breathing improvements can happen gradually over several months. Technical success is vital, but many emphasize the importance of long-term follow-up care.
English-speaking pulmonary hypertension specialists practice at major Turkish medical centers like Anadolu Medical Center and Memorial Healthcare Group. These JCI-accredited facilities provide dedicated international departments. Specialists often hold certifications from the European Society of Cardiology or completed advanced training in London clinics.
Bookimed Expert Insight: Language proficiency in Turkey often follows academic training abroad. Specialists like Dr. Sahin Kaplan and Dr. Alp Burak Catakoglu completed rotations at Imperial College or St. Georges in London. High-volume centers like Anadolu, treating 65,000 patients annually, use dedicated translators to ensure clear communication during complex pulmonary consultations.
Patient Consensus: Patients note that language support is more reliable in large Istanbul private hospitals than in smaller regional clinics. Many recommend bringing translated medication lists and prior catheterization reports to help the cardiology team streamline the initial evaluation.
Patients should plan for a 14 to 21 day stay in Turkey for pulmonary hypertension evaluation and treatment. Diagnostic steps including right heart catheterization usually take 3 to 7 days. Surgical interventions or therapy adjustments often require an additional 10 to 14 days in-hospital.
Bookimed Expert Insight: While basic diagnostics are scheduled quickly, full evaluations often reveal a need for specialized interventions like stem cell therapy. At Valued Med Hub Hospitals, these packages cost approximately $12,000 to $18,000. Choosing a JCI-accredited facility like Memorial Sisli ensures access to 512-slice CT technology, which can significantly speed up the initial diagnostic phase.
Patient Consensus: Patients emphasize that a complete workup is rarely a single appointment and often stretches across several days. Many suggest booking flexible return tickets to allow for phased diagnostic reviews and necessary medication adjustments.